Safety Study of Tivanisiran to Treat Dry Eye

NCT05310422 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

301

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: Tivanisiran sodium ophthalmic solution
DRUG: Vehicle ophthalmic solution

Sponsor

Sylentis, S.A.